Skip to main content
. Author manuscript; available in PMC: 2013 Sep 4.
Published in final edited form as: Mol Pharm. 2012 Aug 6;9(9):2677–2685. doi: 10.1021/mp300243w

Figure 2.

Figure 2

In vitro bactericidal activity of (A) LLA and (B) LipoLLA at different drug concentrations against H. pylori SS1. All concentrations refer to LLA concentration, regardless of the formulation. LLA or LipoLLA was incubated with 5×106 CFU/mL H. pylori SS1 bacteria at 37°C under microaerobic conditions for 30 min followed by Columbia agar plate subculture.